Advertisement

Picture [iito] Back into Ad 650x80px
Organisation › Details

Biogen Idec Inc. (Nasdaq: BIIB)

Biogen Idec creates new standards of care in therapeutic areas with high unmet medical needs. Founded in 1978, Biogen Idec is a global leader in the discovery, development, manufacturing, and commercialization of innovative therapies. Patients worldwide benefit from Biogen Idec's significant products that address diseases such as lymphoma, multiple sclerosis, and rheumatoid arthritis. *

 

Period Start 2003-11-12 merged
Period End 2015-03-23 renamed
  Group Biogen (Group)
  Today Biogen Inc. (Nasdaq: BIIB)
  Predecessor Biogen Inc. (OLD, until 2003)
  Successor Biogen Inc. (Nasdaq: BIIB)
Product Industry BIOTECH
     
  Street 133 Boston Post Road
  City 02493 Weston, MA
  Tel +1-781-464-2000
    Address record changed: 2018-07-24
     
Basic data Employees n. a.
     
    * Document for �About Section�: 
     
   
Record changed: 2018-12-20

Advertisement

Picture ConsulTech GmbH GDPR-compliant E-Col Cloud Document Management 650x80px

More documents for Biogen (Group)


To subscribe to our free, monthly newsletter for the European life sciences, please send an e-mail to info@iito.de and simply fill the subject line with the word »LSE Newsletter«

To get even more information, please take a look at our [gs] professional services offering and read the gene-sensor Product Flyer [PDF file]

Please visit also our web portals for the European life sciences and the worldwide mass spectrometry industry at Life-Sciences-Europe.com (European life sciences) and Mass-Spec-Capital.com (worldwide mass spectrometry)

Please visit also our web portals for the life sciences in German-speaking Europe (DE, AT & CH) and the worldwide mass spectrometry industry at Life-Sciences-Germany.com (life sciences in German-speaking Europe) and Mass-Spec-Capital.com (worldwide mass spectrometry)

Advertisement

Picture [iito] No Content Marketing 650x80px




» top